LATEST NEWS

January, 2012

iSonea Limited Commences Trading on the U.S. OTCQX International

iSonea Limited Announces Publication of Initial Viriathus Research Report

December, 2011

iSonea receives Subscriptions under Rights Issue...

Shareholders Top 20 Listing

Notice of change of interests of substantial holder (RB)

Appendix 3Y: Change of Director’s Interest Notice (RH)

Notice of ceasing to be a substantial holder

Appendix 3Y: Change of Director’s Interest Notice (JK)

Notice Under Section 708A(5) of the Corporations Act

Appendix 3B: New Issue Announcement, Application for Quotation of Additional Securities and Agreement

Dispatch of Renounceable Pro-Rata Rights Issue Closure, Acceptances, Shortfall

Michael Thomas, iSonea CEO talks with BRR on launch of new iPhone Application

Rights Issue Prospectus Announcement

 

iSonea is a dynamic young company built on a solid foundation of clinical expertise. A global leader in developing acoustic respiratory monitoring devices, the Company’s ground breaking products are based on acoustic signal acquisition technology and advanced analysis capabilities. Its proprietary technology responds to an unmet need for accurate, low cost, easy-to-use devices to identify and quantify the presence of wheezes.

Michael Thomas, CEO talks with BRR on launch of new iPhone Application - December 8, 2011

brr


Investor Presentation December 2011


RB Milestone Group: Promising
Technology in an Attractive Industry

Full report


Prestigious Analyst Group begins coverage
of iSonea (formerly Karmelsonix)

Full report

 

© 2011 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin Processor
BlackFin® Processor
KarmelSonix ISO Certification
iSonea
ISO Certification 2003
US Food & Drug Administration

US Food & Drug Administration
Australian Government

Australian Government
Therapeutic Goods Administration


CE Certification

CE Certification